Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
13/03/2015
05/03/2015
04/03/2015
17/02/2015
17/02/2015
29/01/2015
23/01/2015
12/01/2015
07/01/2015
30/12/2014
23/12/2014
17/12/2014
15/12/2014
12/12/2014
10/12/2014
04/12/2014
03/12/2014
27/11/2014
24/11/2014
21/11/2014
17/11/2014
20/10/2014
15/10/2014
16/09/2014
16/09/2014
16/09/2014